Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 3—March 2008

Research

Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City

Ethan E. Bodle*, Jennifer A. Cunningham*, Phyllis Della-Latta*, Neil W. Schluger*, and Lisa Saiman*Comments to Author 
Author affiliations: *Columbia University, New York, New York, USA;

Main Article

Table 3

Comparison of coexisting conditions and concomitant medications with body site of nontuberculous mycobacteria (NTM) disease, New York–Presbyterian Hospital, Columbia University Medical Center, New York, New York, 2000–2003

Site of NTM disease % Patients receiving concomitant medications (n = 79)
Systemic steroids Immunosuppressants Chemotherapeutics Immunomodulators None
Blood (n = 7) 50 33 50 17 17
Respiratory tract (n = 81) 26 13 2 4 70
Skin and soft tissue, surgical sites (n = 21) 17 17 8 8 75
All† 25 15 6 5 66

*Defined as diabetes, chronic renal failure and/or rheumatologic disease.
†Includes 2 patients with disseminated disease following bone marrow transplantation, 1 patient with central nervous system disease receiving steroids, 1 patient with gastrointestinal disease, and 2 patients with lymph node disease/cancer.

Main Article

TOP